Immunogenic cell death as a mechanism of synergy between sunitinib and Lu-DOTATATE peptide receptor radionuclide therapy in pancreatic neuroendocrine tumors.
Cell death discovery
View this publicationCell death discovery
View this publicationWorld journal of urology
View this publicationEuropean journal of nuclear medicine and molecular imaging
View this publicationNeuroImage. Clinical
View this publicationEuropean journal of nuclear medicine and molecular imaging
View this publicationEuropean journal of nuclear medicine and molecular imaging
View this publicationScientific reports
View this publicationRheumatology advances in practice
View this publicationRMD open
View this publicationAlzheimer's & dementia : the journal of the Alzheimer's Association
View this publication